• Home
  • CPD Activities
  • Positioning of Newer Drugs in Type 2 Diabetes Care: The Role of Teneligliptins

Positioning of Newer Drugs in Type 2 Diabetes Care: The Role of Teneligliptins

NameWorld Continuing Education Alliance
Activity TitlePositioning of Newer Drugs in Type 2 Diabetes Care: The Role of Teneligliptins
DetailsBy Dr. Robert Kalyesubula, MBChB, Mmed, FISN (USA), FCS (ECSA), PhD-FRCP(London) Epidemiology of Diabetes, Physiology of glucose metabolism, Incretins, DPP4- inhibitors (Teneligliptin) DM care, DKD mgt
CompetenceInternal Medicine
Start Date<span class="not-set">(not set)</span>
End Date<span class="not-set">(not set)</span>
Event Time05:00 AM
LocationWorld Continuing Education Alliance eLearning System/Uganda Kidney Foundation
Cost (UGX)0
CPD Points2